Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E.V. Dressler
Medical Oncologists’ Perception of Anti-Estrogen Therapy Benefit in Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer
Annals of Oncology
Medicine
Oncology
Hematology
Related publications
Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer
JAMA Oncology
Cancer Research
Oncology
Oncofertility Counselling in Premenopausal Women With HER2-positive Breast Cancer
Oncotarget
Oncology
Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
Frontiers in Oncology
Cancer Research
Oncology
A Randomized Phase II Presurgical Trial of Weekly Low-Dose Tamoxifen Versus Raloxifene Versus Placebo in Premenopausal Women With Estrogen Receptor-Positive Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Factors Determining Anthracycline Use in Hormone Receptor Positive, Early Stage Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor–Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Cost Effectiveness of Fulvestrant 500 Mg in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer in the UK
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Phase 1b Study of Orteronel in Postmenopausal Women With Hormone-Receptor Positive (HR+) Metastatic Breast Cancer
Investigational New Drugs
Oncology
Pharmacology
Quantitative ER and PgR Assessment as Predictors of Benefit From Lapatinib in Postmenopausal Women With Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
